Immunologist, Cell biologist

Joel Buxbaum, MD

Joel Buxbaum, MD is a Professor of molecular medicine emeritus at The Scripps Research Institute and Consulting Chief Medical Officer at Protego Biopharma, La…

Subscribe to

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion